双重自组装的dermatan硫酸盐/chitosan纳米颗粒用于癌症治疗中的向siRNA输送
Dareen Sader1, Ivan Zlotver1, Sergio Moya2
1Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering Technion - Israel Institute of Technology, Technion City 320003, Haifa, Israel.
Journal of colloid and interface science
|November 24, 2024
概括
这项研究提出了一种新的微流体方法,用于在纳米粒子中封装小干扰RNA (siRNA). 这些纳米颗粒有效地向并抑制三阴性乳腺癌细胞中的幸存者,显示为基因治疗的前景.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 癌症基因治疗 基因治疗
背景情况:
- RNA干扰 (RNAi) 为癌症治疗提供了基因特异性抑制.
- 幸存者 (BIRC5) 对于三阴性乳腺癌 (TNBC) 扩散和转移至关重要.
研究的目的:
- 开发一种微流体方法,在纳米粒子中封装针对BIRC5的siRNA.
- 为了创建针对TNBC的向纳米颗粒,使用奇多-移植-多 (甲基甲酸) 和dermatan硫酸盐.
主要方法:
- 基于微流体的双重自我组装 (化和聚电解质复合体形成).
- 在两性共聚物和dermatan硫酸盐纳米颗粒中封装BIRC5-向siRNA.
- 纳米颗粒的特征 (大小,泽塔潜力) 和评估4T1TNBC细胞中的向和传递.
主要成果:
- 产生了具有出色物理稳定性的球形纳米粒子 (~200nm).
- 德马坦硫酸盐在4T1细胞中促进了活性向和细胞内传递.
- 在实验室中有效地对生存素进行沉默,导致4T1细胞活力,迁移和球形形成的减少.
结论:
- 为siRNA纳米封装展示了一种简单,可扩展的微流体方法.
- 开发的纳米颗粒显示了TNBC基因治疗的巨大潜力.
- 在TNBC模型中证实了向性传递和基因沉默.
更多相关视频
08:31Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10.6K
相关概念视频
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
